Skip to content
411 PRESS
WarningRecall #D-0607-2026Drug / Pharmaceutical

SUN PHARMACEUTICAL INDUSTRIES INC Recalls Budesonide Inhalation Suspension

SUN PHARMACEUTICAL INDUSTRIES INC · Class II — Moderate Risk

Assorted pharmaceutical pills and tablets — representative photo for FDA drug recall
An assortment of pharmaceutical pills (representative file photo). Specific recalled product: see recall details below. Photo: Michael Nutt / Wikimedia Commons (CC BY-SA 2.0).

Product Description

Budesonide Inhalation Suspension, 1mg/2mL, 30 x 2 mL Sterile Single-Dose Ampules (5 Single-Dose Ampules per pouch, 6 pouches per carton, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Baska Ujeti Road, Ujeti Halol-289350, Gujarat, India, NDC 47335-633-49.

Reason for Recall

Presence of Foreign Substance:This recall has been initiated in response to a product quality complaint reported for black/brown specs and particles within the ampoule solution

FDA Classification

Class II — Moderate Risk

A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

Distribution

Nationwide within the United States

Remedy

Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.

411 Press Analysis

A Class II FDA recall has been issued for a pharmaceutical product from SUN PHARMACEUTICAL INDUSTRIES INC, initiated on May 29, 2026. Presence of Foreign Substance:This recall has been initiated in response to a product quality complaint reported for black/brown specs and particles within the ampoule solution. The product was distributed nationwide. While not the highest severity, consumers should exercise caution and stop using the product until the recall is resolved.

Independent news on labor, safety, and accountability.